651 CMR 15.08
Formulary
651 CMR 15.08 applies only to the Formulary developed and maintained by the Plan.
Members of a Medicare Part D Plan shall refer to their Medicare Part D Plan Formulary to
determine its rules and the included Prescription Drugs.
(1) The Plan will develop and maintain a Plan Formulary consisting of a list of Prescription
Drugs. The Plan Formulary shall include insulin and disposable insulin syringes and needles.
The Plan shall maintain a toll-free telephone number during business hours through which an
Applicant or Member or his or her authorized representative may determine whether a particular
Prescription Drug is included on the Plan Formulary.
(2) The Plan shall review the Plan Formulary and modify it as appropriate.
(3) The Plan shall not exclude any Prescription Drug from the Plan Formulary unless a
Therapeutically Equivalent Prescription Drug is included on the Plan Formulary; however, the
Secretary may exclude certain outpatient Prescription Drugs or classes of outpatient Prescription
Drugs upon a written determination pursuant to M.G.L. 19A, § 39(r) that the exclusion is
necessary to maintain the fiscal viability of the program.
(4) Excluded from the Plan Formulary are Prescription Drugs labeled "Caution - limited by
federal law to investigational use" or experimental drugs.
(5) To ensure appropriate use of Covered Benefits, the Plan may require Prior Authorization
and/or implement benefit management tools, including quantity limitations for certain
Prescription Drugs.
(6) Members shall have the right to seek a Review of the following:
(a) a Member's request to obtain a Non-preferred drug at the Co-payment level of a
Preferred Drug;
(b) a Member's request to add to the Plan Formulary a Prescription Drug excluded from the
Plan Formulary; or
(c) a Member's request to gain access to a Prescription Drug excluded from the Plan
Formulary at Plan Formulary rates.